Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$1.27B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$570M |
| 3 |
Chipotle Mexican Grill
CMG
|
$298M |
| 4 |
Oneok
OKE
|
$279M |
| 5 |
Ameren
AEE
|
$252M |
Top Sells
| 1 |
Apple
AAPL
|
$418M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$407M |
| 3 |
Atlassian
TEAM
|
$364M |
| 4 |
United Parcel Service
UPS
|
$342M |
| 5 |
Advanced Micro Devices
AMD
|
$295M |
Sector Composition
| 1 | Technology | 31.61% |
| 2 | Healthcare | 19.69% |
| 3 | Financials | 10.19% |
| 4 | Industrials | 9.75% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
ProKidney
PROK
$310M
| $86.2K | ﹤0.01% |
18,793
-87
| -0.5% | -$399 |
|
|
TWOU
2527
DELISTED
2U, Inc.
TWOU
| $85.2K | ﹤0.01% |
1,147
| – | – |
|
2528
ARS Pharmaceuticals
SPRY
$1.06B
| $82.9K | ﹤0.01% |
21,883
+4
| +0% | +$15 |
|
2529
Erasca
ERAS
$420M
| $80.5K | ﹤0.01% |
40,746
+1
| +0% | +$2 |
|
2530
Future Fuel
FF
$172M
| $80K | ﹤0.01% |
11,160
+1
| +0% | +$7 |
|
2531
ATAI Life Sciences
ATAI
$977M
| $78.9K | ﹤0.01% |
61,391
-4
| -0% | -$5 |
|
2532
Clarus
CLAR
$139M
| $77.1K | ﹤0.01% |
10,197
+2
| +0% | +$15 |
|
|
ALLK
2533
DELISTED
Allakos
ALLK
| $76.4K | ﹤0.01% |
33,566
+27
| +0.1% | +$61 |
|
2534
Fate Therapeutics
FATE
$112M
| $72.2K | ﹤0.01% |
33,963
+9
| +0% | +$19 |
|
2535
1-800-Flowers.com
FLWS
$329M
| $71.3K | ﹤0.01% |
10,206
+3
| +0% | +$21 |
|
2536
Expensify
EXFY
$177M
| $69.9K | ﹤0.01% |
21,545
+1
| +0% | +$3 |
|
2537
Nuvation Bio
NUVB
$1.17B
| $69.7K | ﹤0.01% |
51,417
+7
| +0% | +$9 |
|
2538
Emergent Biosolutions
EBS
$407M
| $69.3K | ﹤0.01% |
20,359
+55
| +0.3% | +$187 |
|
2539
Angi Inc
ANGI
$794M
| $59K | ﹤0.01% |
2,972
+1
| +0% | +$20 |
|
2540
Butterfly Network
BFLY
$385M
| $57.6K | ﹤0.01% |
48,593
-5
| -0% | -$6 |
|
|
AGEN
2541
Agenus
AGEN
$137M
| $57.5K | ﹤0.01% |
2,556
+12
| +0.5% | +$270 |
|
2542
Blink Charging
BLNK
$117M
| $53.7K | ﹤0.01% |
17,583
+28
| +0.2% | +$86 |
|
2543
Rackspace Technology
RXT
$311M
| $51.4K | ﹤0.01% |
21,903
| – | – |
|
|
TPIC
2544
DELISTED
TPI Composites
TPIC
| $43K | ﹤0.01% |
16,240
-1
| -0% | -$3 |
|
2545
Sight Sciences
SGHT
$195M
| $41.7K | ﹤0.01% |
12,369
| – | – |
|
2546
Rimini Street
RMNI
$406M
| $41.1K | ﹤0.01% |
18,658
+5
| +0% | +$11 |
|
|
KLRS
2547
Kalaris Therapeutics, Inc. Common Stock
KLRS
$87.2M
| $40.7K | ﹤0.01% |
825
+5
| +0.6% | +$247 |
|
2548
Mersana Therapeutics
MRSN
$35.5M
| $38.8K | ﹤0.01% |
1,226
+1
| +0.1% | +$32 |
|
2549
Traeger
COOK
$190M
| $33.6K | ﹤0.01% |
12,324
+123
| +1% | +$335 |
|
2550
Lexicon Pharmaceuticals
LXRX
$389M
| $32K | ﹤0.01% |
29,470
+335
| +1% | +$364 |
|